Literature DB >> 35357564

Novel insights into the effects of levodopa on the up- and downstrokes of writing sequences.

Sanne Broeder1, Leonardo Boccuni2,3,4, Britt Vandendoorent5, Geert Verheyden5, Raf Meesen6,7, Alice Nieuwboer5.   

Abstract

Motor control of automatized and overlearned sequences, such as writing, is affected in Parkinson's disease (PD), impacting patients' daily life. Medication effects on motor performance are not only task-specific, but also variable within tasks. The nature of this variance is still unclear. This study aimed to investigate whether medication affects writing sequences differently when producing up- or downstrokes. Writing was assessed in healthy controls (HC) (N = 31) and PD (N = 32), when ON and OFF medication in a randomized order (interspersed by two months). Subjects wrote a sequential pattern with an increasing size on a digital tablet. Writing outcomes were movement vigor (amplitude and velocity), error and end-point variability, and sequence continuation, calculated separately for up- and downstrokes. Results showed that PD patients OFF-medication reduced movement vigor (amplitude) for up- and downstrokes compared to HC. Clear deficits were found for up- but not for downstroke error in PD patients in OFF, suggesting a directional bias. Dopaminergic medication improved motor vigor by increasing writing amplitude and upstroke continuation, but this occurred at the cost of the downstroke trajectory. Other writing outcomes did not improve with medication intake. In conclusion, we interpret these findings as that the impact of dopamine is complex, highly task-specific, supporting the most highly energy demanding components of a writing sequence. As medication did not regulate downstroke writing, we recommend supplementary training to address task demands that were less modulated by dopamine (registration: https://osf.io/gk5q8/ , 17 July 2018).
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Dopaminergic medication; Dysgraphia; Handwriting; Motor control; Parkinson’s disease

Mesh:

Substances:

Year:  2022        PMID: 35357564     DOI: 10.1007/s00702-022-02493-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.850


  29 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease.

Authors:  Alberto J Espay; Joe P Giuffrida; Robert Chen; Megan Payne; Filomena Mazzella; Emily Dunn; Jennifer E Vaughan; Andrew P Duker; Alok Sahay; Sang Jin Kim; Fredy J Revilla; Dustin A Heldman
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

3.  The effects of dual tasking on handwriting in patients with Parkinson's disease.

Authors:  S Broeder; E Nackaerts; A Nieuwboer; B C M Smits-Engelsman; S P Swinnen; E Heremans
Journal:  Neuroscience       Date:  2014-01-19       Impact factor: 3.590

Review 4.  Dopamine and the motivation of cognitive control.

Authors:  Roshan Cools; Monja Froböse; Esther Aarts; Lieke Hofmans
Journal:  Handb Clin Neurol       Date:  2019

5.  Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease.

Authors:  Quincy J Almeida; James S Frank; Eric A Roy; Aftab E Patla; Mandar S Jog
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

Review 6.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

7.  Biased wrist and finger coordination in Parkinsonian patients during performance of graphical tasks.

Authors:  Natalia Dounskaia; Arend W A Van Gemmert; Berta C Leis; George E Stelmach
Journal:  Neuropsychologia       Date:  2009-05-04       Impact factor: 3.139

8.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

9.  Movement Speed-Accuracy Trade-Off in Parkinson's Disease.

Authors:  Laure Fernandez; Raoul Huys; Johann Issartel; Jean-Philippe Azulay; Alexandre Eusebio
Journal:  Front Neurol       Date:  2018-10-24       Impact factor: 4.003

10.  Dopamine promotes instrumental motivation, but reduces reward-related vigour.

Authors:  John P Grogan; Timothy R Sandhu; Michele T Hu; Sanjay G Manohar
Journal:  Elife       Date:  2020-10-01       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.